Unlocking Global Market Access
Presented exclusively for members of the California Life Sciences Association
Please complete the form below to view the webinar recording.
Thinking about taking your drug overseas? Early decisions made during clinical trial design are inextricably linked to later evaluations of drug cost-effectiveness by international health technology assessment (HTA) agencies--one of the critical differences from a US-only strategy. This webinar provides an insightful discussion exploring the specific challenges to global market access for biotechnology companies including:
How do HTA agencies function within their healthcare systems and relate to reimbursement?
What are the requirements of HTA agencies and key drivers of decision-making?
What are the important clinical and economic considerations during development?
How can historical HTA data inform strategies and requirements for new drugs entering the market?